Anaesthetic management of an adult patient with X-linked adrenoleukodystrophy.
OBJECTIVE
Adrenoleukodystrophy (ALD) is a rare genetic disorder. Findings include various central nervous system problems in addition to adrenal insufficiency. We present a case of an adult man with X-linked ALD undergoing surgery.


METHODS
A 40-yr-old man with X-linked ALD presented with an intertrochanteric femoral fracture. Past medical history included recurrent lung atelectasis, urinary incontinence, mental retardation, seizure disorder, and adrenal insufficiency. No sedative pre-medications were ordered, but perioperative steroid coverage with 100 mg hydrocortisone was initiated. In the operating room, the patient would not allow placement of all monitors. Therefore, 1 mg midazolam then 275 mg thiopentone followed immediately by 40 mg rocuronium were used to induce anesthesia with the application of cricoid pressure and the remaining monitors. Fentanyl 50 micrograms i.v. was given soon after induction, and anaesthesia was maintained with nitrous oxide and isoflurane. No further muscle relaxant or opioid was administered and anaesthesia was uneventful. The trachea was extubated with the patient awake and he was taken to the recovery area in stable condition.


CONCLUSIONS
Patients with X-linked ALD are rarely seen in a clinical setting because the condition is so uncommon. Adrenal insufficiency, mental retardation, and osteoporosis are major considerations for these patients. In addition, these patients are at risk for reflux, seizures, and major post-operative complications.
Kindopp
A S
AS
Department of Anaesthesia, Kingston General Hospital, Queen's University, Ontario, Canada.
Ashbury
T
T
D000326:Adrenoleukodystrophy / Q000235:genetics* / Q000503:physiopathology; D000328:Adult; D000732:Androstanols / Q000008:administration & dosage; D000762:Anesthesia Recovery Period; D000768:Anesthesia, General / Q000379:methods*; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005283:Fentanyl / Q000008:administration & dosage; D008040:Genetic Linkage / Q000235:genetics*; D006620:Hip Fractures / Q000601:surgery; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007430:Intraoperative Care; D007442:Intubation, Intratracheal; D007530:Isoflurane / Q000008:administration & dosage; D008297:Male; D008874:Midazolam / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage; D009609:Nitrous Oxide / Q000008:administration & dosage; D000077123:Rocuronium; D013874:Thiopental / Q000627:therapeutic use; D014960:X Chromosome / Q000235:genetics*
D000732:Androstanols; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D000893:Anti-Inflammatory Agents; D006993:Hypnotics and Sedatives; D003473:Neuromuscular Nondepolarizing Agents; D007530:Isoflurane; D013874:Thiopental; D009609:Nitrous Oxide; D008874:Midazolam; D005283:Fentanyl; D006854:Hydrocortisone; D000077123:Rocuronium